Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.

We present here a method for the rapid determination of the intact mass of noncovalently associated antibody heavy chains (HC) and light chains (LC) which result from the attachment of drug conjugates to interchain cysteine residues. By analyzing the antibody-drug conjugate (ADC) using native desalting conditions, we maintain the intact bivalent structure of the ADC, which ordinarily would decompose as a consequence of denaturing chromatographic conditions typically used for liquid chromatographic-mass spectrometric (LC-MS) analysis. The mass of the desalted ADC is subsequently determined using standard desolvation and ionization conditions. Methods presented previously in the literature for analyzing interchain cysteinyl-linked ADCs are either not amenable to online mass spectrometry or result in the denaturing dissociation of conjugated HC and LC during chromatographic separation and subsequent mass measurement. We have avoided this outcome with our method and have successfully and routinely obtained intact mass measurement of IgG1 mAbs conjugated with maleimidocaproyl-monomethyl Auristatin F (mcMMAF) and valine-citrulline-monomethyl Auristatin E (vcMMAE) at interchain cysteine residues. Our results thus represent the first reported direct measurement of the intact mass of an ADC conjugated at interchain cysteine residues.

[1]  M. Gross,et al.  Native electrospray and electron-capture dissociation in FTICR mass spectrometry provide top-down sequencing of a protein component in an intact protein assembly , 2010, Journal of the American Society for Mass Spectrometry.

[2]  K. Aldape,et al.  A model of molecular interactions on short oligonucleotide microarrays , 2003, Nature Biotechnology.

[3]  P. Schnier,et al.  Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.

[4]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  A. Heck,et al.  Probing noncovalent protein—Ligand interactions of the cGMP-dependent protein kinase using electrospray ionization time of flight mass spectrometry , 2004, Journal of the American Society for Mass Spectrometry.

[6]  D. J. Douglas,et al.  Stability of a highly charged noncovalent complex in the gas phase: holomyoglobin. , 1998, Rapid communications in mass spectrometry : RCM.

[7]  C. Enke,et al.  A predictive model for matrix and analyte effects in electrospray ionization of singly-charged ionic analytes. , 1997, Analytical chemistry.

[8]  F. Zal,et al.  Comparative ESI-MS study of ∼2.2 MDa native hemocyanins from deep-sea and shore crabs: from protein oligomeric state to biotope , 2003 .

[9]  L. Konermann,et al.  Signal response of coexisting protein conformers in electrospray mass spectrometry. , 2007, Analytical chemistry.

[10]  A. Lazar,et al.  Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[11]  Vasco Filipe,et al.  Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography , 2010, Pharmaceutical Research.

[12]  John F. Valliere-Douglass,et al.  Molecular mass analysis of antibodies by on-line SEC-MS , 2008, Journal of the American Society for Mass Spectrometry.

[13]  B. Ganem,et al.  Mass Spectrometric Investigations of Drug‐Receptor Interactions , 1993, Therapeutic drug monitoring.

[14]  Sheng Yin,et al.  Mass spectrometry detection and characterization of noncovalent protein complexes. , 2009, Methods in molecular biology.

[15]  R. Heeren,et al.  Monitoring macromolecular complexes involved in the chaperonin-assisted protein folding cycle by mass spectrometry , 2005, Nature Methods.

[16]  D. Benjamin,et al.  Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate , 2010, Clinical Cancer Research.

[17]  Stephen C Alley,et al.  Antibody-drug conjugates: targeted drug delivery for cancer. , 2010, Current opinion in chemical biology.

[18]  A. Nesterova,et al.  Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75 , 2010, British Journal of Cancer.

[19]  Aditya A Wakankar,et al.  Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. , 2010, Bioconjugate chemistry.

[20]  L. Presta,et al.  Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. , 1996, Biochemistry.

[21]  Michael M C Sun,et al.  Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides. , 2005, Bioconjugate chemistry.

[22]  C. Enke,et al.  Effect of affinity for droplet surfaces on the fraction of analyte molecules charged during electrospray droplet fission. , 2001, Analytical chemistry.

[23]  B. Yan,et al.  HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  P. Carter,et al.  Antibody-Drug Conjugates for Cancer Therapy , 2008, Cancer journal.

[25]  Surinder Kaur,et al.  Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. , 2011, Analytical biochemistry.

[26]  D. J. Douglas,et al.  Unfolding of proteins monitored by electrospray ionization mass spectrometry: a comparison of positive and negative ion modes , 1998, Journal of the American Society for Mass Spectrometry.

[27]  Alain Balland,et al.  Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. , 2008, Journal of chromatography. A.

[28]  Damon L. Meyer,et al.  Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. , 2006, Bioconjugate chemistry.

[29]  Aditya A Wakankar,et al.  Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.

[30]  B. Boys,et al.  Analysis of protein mixtures by electrospray mass spectrometry: Effects of conformation and desolvation behavior on the signal intensities of hemoglobin subunits , 2007, Journal of the American Society for Mass Spectrometry.